Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Week twenty-four
Athletes subject to anti-doping testing must not use MOTS-c
Designed to support energy, hydration, and daily wellness while on GLP-1 medication.
Long-Term Safety: What We Know and Don't Know What We Know (From TRIUMPH-4 and TRIUMPH-1) Up to 80 weeks of data: Side effects improve significantly after dose escalation (first 16 weeks hardest) No unexpected safety signals in either trial Dysesthesia doesn't worsen over time (stable) Discontinuation rates stabilize (most who stop do so in first 24 weeks) No deaths attributed to retatrutide in any completed trial TRIUMPH-1 104-week extension shows continued weight loss without new safety signals What We Don't Know Yet Longer-term questions (need 25+ years data): Does dysesthesia resolve completely if medication stopped
Survodutide showed similar glycemic benefits, with Phase 2 data demonstrating substantial HbA1c reductions across dose levels
Swirl gently, never shake, as vigorous agitation promotes aggregation
US$ 28.71
US$ 26.70
US$ 21.66
US$ 25.48
